{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:54:20Z","timestamp":1769522060680,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"DOI":"10.1007\/s12031-025-02386-9","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T10:34:13Z","timestamp":1754130853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Demographic, Clinical, and Molecular Determinants of Quality of Life and Oxidative Stress in Multiple Sclerosis: A Cross-Sectional Study from Sulaymaniyah, Iraq"],"prefix":"10.1007","volume":"75","author":[{"given":"Dlzar Dlshad","family":"Ghafoor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dlshad Omar","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarwer Jamal","family":"Al-Bajalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"2386_CR1","doi-asserted-by":"publisher","first-page":"103994","DOI":"10.1016\/j.msard.2022.103994","volume":"65","author":"DSSK Boorgu","year":"2022","unstructured":"Boorgu DSSK et al (2022) The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis. Mult Scler Relat Disord 65:103994. https:\/\/doi.org\/10.1016\/j.msard.2022.103994","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"2386_CR2","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3390\/diagnostics12061365","volume":"12","author":"A Burgetova","year":"2022","unstructured":"Burgetova A et al (2022) Oxidative stress markers in cerebrospinal fluid of newly diagnosed multiple sclerosis patients and their link to iron deposition and atrophy. Diagnostics (Basel) 12(6):1365. https:\/\/doi.org\/10.3390\/diagnostics12061365","journal-title":"Diagnostics (Basel)"},{"issue":"8","key":"2386_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1212\/WNL.0000000000012323","volume":"97","author":"BAC Cree","year":"2021","unstructured":"Cree BAC et al (2021) Secondary progressive multiple sclerosis. Neurology 97(8):378\u2013388. https:\/\/doi.org\/10.1212\/WNL.0000000000012323","journal-title":"Neurology"},{"key":"2386_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/1678-4685-GMB-2017-0334","volume":"42","author":"JA de Oliveira-Silva","year":"2019","unstructured":"de Oliveira-Silva JA et al (2019) Oxidative stress assessment by glutathione peroxidase activity and glutathione levels in response to selenium supplementation in patients with Mucopolysaccharidosis I, II and VI. Genet Mol Biol 42:1\u20138. https:\/\/doi.org\/10.1590\/1678-4685-GMB-2017-0334","journal-title":"Genet Mol Biol"},{"key":"2386_CR5","doi-asserted-by":"publisher","first-page":"612953","DOI":"10.3389\/fncel.2020.612953","volume":"14","author":"L Ferr\u00e8","year":"2020","unstructured":"Ferr\u00e8 L, Filippi M, Esposito F (2020) Involvement of genetic factors in multiple sclerosis. Front Cell Neurosci 14:612953. https:\/\/doi.org\/10.3389\/fncel.2020.612953","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"2386_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12931-020-1292-7","volume":"21","author":"AM Fratta Pasini","year":"2020","unstructured":"Fratta Pasini AM et al (2020) Oxidative stress and Nrf2 expression in peripheral blood mononuclear cells derived from COPD patients: an observational longitudinal study. Respiratory Research 21(1):37. https:\/\/doi.org\/10.1186\/s12931-020-1292-7","journal-title":"Respir Res"},{"issue":"11","key":"2386_CR7","doi-asserted-by":"publisher","first-page":"e041249","DOI":"10.1136\/bmjopen-2020-041249","volume":"10","author":"I Gil-Gonz\u00e1lez","year":"2020","unstructured":"Gil-Gonz\u00e1lez I, Mart\u00edn-Rodr\u00edguez A, Conrad R, P\u00e9rez-San-Gregorio M\u00c1 (2020) Quality of life in adults with multiple sclerosis: a systematic review. BMJ Open 10(11):e041249. https:\/\/doi.org\/10.1136\/bmjopen-2020-041249","journal-title":"BMJ Open"},{"key":"2386_CR8","doi-asserted-by":"publisher","first-page":"175628642311807","DOI":"10.1177\/17562864231180734","volume":"16","author":"R Gold","year":"2023","unstructured":"Gold R et al (2023) Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method. Ther Adv Neurol Disord 16:17562864231180734. https:\/\/doi.org\/10.1177\/17562864231180734","journal-title":"Ther Adv Neurol Disord"},{"issue":"9","key":"2386_CR9","doi-asserted-by":"publisher","first-page":"e2334675","DOI":"10.1001\/jamanetworkopen.2023.34675","volume":"6","author":"A He","year":"2023","unstructured":"He A et al (2023) Premorbid sociodemographic status and multiple sclerosis outcomes in a universal health care context. JAMA Netw Open 6(9):e2334675. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.34675","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2386_CR10","doi-asserted-by":"publisher","first-page":"fcad356","DOI":"10.1093\/braincomms\/fcad356","volume":"6","author":"A Houldsworth","year":"2024","unstructured":"Houldsworth A (2024) \u201cRole of oxidative stress in neurodegenerative disorders: a review of reactive oxygen species and prevention by antioxidants. Brain Communications 6(1):fcad356. https:\/\/doi.org\/10.1093\/braincomms\/fcad356","journal-title":"Brain Commun"},{"key":"2386_CR11","doi-asserted-by":"publisher","unstructured":"Korkmaz KS, Butuner BD, Roggenbuck D (2018) Detection of 8-OHdG as a diagnostic biomarker. J Lab Precis Med 3(0)Art. no.0.https:\/\/doi.org\/10.21037\/jlpm.2018.11.01","DOI":"10.21037\/jlpm.2018.11.01"},{"issue":"9","key":"2386_CR12","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1093\/brain\/awac016","volume":"145","author":"FD Lublin","year":"2022","unstructured":"Lublin FD et al (2022) How patients with multiple sclerosis acquire disability. Brain 145(9):3147\u20133161. https:\/\/doi.org\/10.1093\/brain\/awac016","journal-title":"Brain"},{"key":"2386_CR13","doi-asserted-by":"publisher","first-page":"1437939","DOI":"10.3389\/fphar.2024.1437939","volume":"15","author":"C Mayer","year":"2024","unstructured":"Mayer C, Riera-Ponsati L, Kauppinen S, Klitgaard H, Erler JT, Hansen SN (2024) Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implications. Front Pharmacol 15:1437939. https:\/\/doi.org\/10.3389\/fphar.2024.1437939","journal-title":"Front Pharmacol"},{"issue":"3","key":"2386_CR14","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1194\/jlr.D032698","volume":"54","author":"HF Moselhy","year":"2013","unstructured":"Moselhy HF, Reid RG, Yousef S, Boyle SP (2013) A specific, accurate, and sensitive measure of total plasma malondialdehyde by HPLC [S]. J Lipid Res 54(3):852\u2013858. https:\/\/doi.org\/10.1194\/jlr.D032698","journal-title":"J Lipid Res"},{"issue":"6","key":"2386_CR15","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1007\/s12035-015-9337-5","volume":"53","author":"E Niedzielska","year":"2016","unstructured":"Niedzielska E et al (2016) Oxidative stress in neurodegenerative diseases. Mol Neurobiol 53(6):4094\u20134125. https:\/\/doi.org\/10.1007\/s12035-015-9337-5","journal-title":"Mol Neurobiol"},{"issue":"4","key":"2386_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1399-0039.1992.tb01935.x","volume":"39","author":"M Ota","year":"1992","unstructured":"Ota M, Seki T, Fukushima H, Tsuji K, Inoko H (1992) HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 39(4):187\u2013202. https:\/\/doi.org\/10.1111\/j.1399-0039.1992.tb01935.x","journal-title":"Tissue Antigens"},{"key":"2386_CR17","doi-asserted-by":"publisher","first-page":"100484","DOI":"10.1016\/j.bbih.2022.100484","volume":"24","author":"DS Peres","year":"2022","unstructured":"Peres DS et al (2022) Prevalence of depression and anxiety in the different clinical forms of multiple sclerosis and associations with disability: a systematic review and meta-analysis. Brain, Behavior, & Immunity - Health 24:100484. https:\/\/doi.org\/10.1016\/j.bbih.2022.100484","journal-title":"Brain Behav Immun Health"},{"issue":"7359","key":"2386_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature10251","volume":"476","author":"S Sawcer","year":"2011","unstructured":"Sawcer S et al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476(7359):214\u2013219. https:\/\/doi.org\/10.1038\/nature10251","journal-title":"Nature"},{"key":"2386_CR19","doi-asserted-by":"publisher","unstructured":"Silva-Llanes I, Shin CH, Jim\u00e9nez-Villegas J, Gorospe M, Lastres-Becker I (2023) The transcription factor NRF2 has epigenetic regulatory functions modulating HDACs, DNMTs, and miRNA biogenesis. Antioxidants 12(3).https:\/\/doi.org\/10.3390\/antiox12030641","DOI":"10.3390\/antiox12030641"},{"issue":"24","key":"2386_CR20","doi-asserted-by":"publisher","first-page":"17223","DOI":"10.3390\/ijms242417223","volume":"24","author":"D Tonev","year":"2023","unstructured":"Tonev D, Momchilova A (2023) Oxidative stress and the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway in multiple sclerosis: focus on certain exogenous and endogenous Nrf2 activators and therapeutic plasma exchange modulation. Int J Mol Sci 24(24):17223. https:\/\/doi.org\/10.3390\/ijms242417223","journal-title":"Int J Mol Sci"},{"key":"2386_CR21","doi-asserted-by":"publisher","first-page":"104117","DOI":"10.1016\/j.msard.2022.104117","volume":"68","author":"C Tornatore","year":"2022","unstructured":"Tornatore C et al (2022) Identification of cognitive impairment, depression, and fatigue among multiple sclerosis patients in a large comprehensive care center: a mixed-methods, qualitative study. Multiple Sclerosis and Related Disorders 68:104117. https:\/\/doi.org\/10.1016\/j.msard.2022.104117","journal-title":"Multiple Scler Relate Dis"},{"issue":"8","key":"2386_CR22","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.freeradbiomed.2010.07.013","volume":"49","author":"J van Horssen","year":"2010","unstructured":"van Horssen J, Drexhage JAR, Flor T, Gerritsen W, van der Valk P, de Vries HE (2010) Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions. Free Radical Biol Med 49(8):1283\u20131289. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.07.013","journal-title":"Free Radical Biol Med"},{"issue":"Suppl 5 Improvi","key":"2386_CR23","first-page":"S139","volume":"17","author":"HL Zwibel","year":"2021","unstructured":"Zwibel HL, Smrtka J (2021) Improving quality of life in multiple sclerosis: an unmet need. Am J Manag Care 17(Suppl 5 Improving):S139\u2013S145","journal-title":"Am J Manag Care"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-025-02386-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-025-02386-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-025-02386-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T15:18:22Z","timestamp":1759763902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-025-02386-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["2386"],"URL":"https:\/\/doi.org\/10.1007\/s12031-025-02386-9","relation":{},"ISSN":["1559-1166"],"issn-type":[{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}